Poland – Pharmaceutical products – Delivery of a drug for a clinical trial (Tirzepatid)
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
The subject of the proceedings is the supply of a drug for a clinical trial (Tirzepatid). The order is carried out as part of a project financed from the state budget by the Medical Research Agency, Project number 2025/ABM/01/00044 "Non-commercial, randomized, controlled Phase III head-to-head clinical trial, assessing the effectiveness and safety of the use of tirzepatide and/or intensive insulin therapy in the model of continuous subcutaneous insulin infusion using an automatic, advanced hybrid closed-loop system in patients with chronically uncontrolled type 1 diabetes.